Benzinga | Oct 27, 2021 07:05AM EDT

Teva Pharmaceutical Indus Q3 Adj. EPS $0.59 Misses $0.65 Estimate, Sales $3.89B Miss $4.03B Estimate; Reaffirms Guidance

Teva Pharmaceutical Indus (NYSE:TEVA) reported quarterly earnings of $0.59 per share which missed the analyst consensus estimate of $0.65 by 9.23 percent. This is a 1.72 percent increase over earnings of $0.58 per share from the same period last year. The company reported quarterly sales of $3.89 billion which missed the analyst consensus estimate of $4.03 billion by 3.55 percent. This is a 2.29 percent decrease over sales of $3.98 billion the same period last year.